Mobile Continuing Care Approach for Youth

July 28, 2015 updated by: Azusa Pacific University
The primary purpose of this study is to test the effectiveness of a pilot mobile based continuing care program (monitoring/feedback texting) relative to standard continuing care as usual in reducing relapse and improving psychosocial functioning outcomes in a youth population (under 24) with substance abuse problems.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This study will include approximately 80 participants randomized to either 12 weeks of mobile continuing care (intervention) or standard continuing care as usual (control). Participants will be recruited from the treatment programs in Los Angeles County, including Matrix Institute on Addictions, Tarzana Treatment, Twin Town, Phoenix House, and Cri-Help. During the 12-week active program, participants will be monitored monthly via telephone data collection. Both groups will be followed for 10-months using repeated assessments (self-report and urine specimens) at baseline (month 0) and at follow-up points (months 3, 6, and 9).

Study Type

Interventional

Enrollment (Actual)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • California
      • Azusa, California, United States, 91702
        • Azusa Pacific University Psychology Department

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years to 24 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Youth between 12 and 24 years old
  2. Youth in treatment for substance abuse
  3. Youth who complete treatment (minimum 12 weeks)
  4. Youth who have the cognitive capacity to understand study procedures and agree to participate

Exclusion Criteria:

  1. Presence of an adverse (life threatening) medical condition that could interfere with study participation.
  2. Presence of psychiatric co-occurring illness or symptoms warranting safety concerns or continued treatment, including acute suicide risk; and
  3. Current homelessness (unless residing in recovery home for which contact information can be provided).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Mobile Continuing Care
Behavioral: 12-week Structured Texting intervention focused on recovery monitoring, feedback for self-management, social support and education
Behavioral: Mobile Continuing Care
Behavioral: Mobile Texting 12-week intervention. Delivers daily Recovering monitoring, self-management feedback, and education/social support
No Intervention: Standard Continuing Care as Usual
Continuing care as usual to 12-step facilitation (Anonymous group)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Primary Substance Use (Defined as Substance Received Treatment for)
Time Frame: Baseline, discahrge, 3 month follow-up, 6 month follow-up, 9 month follow-up
Primary substance use relapse was measured by urine tests (0 = negative, 1 = positive).
Baseline, discahrge, 3 month follow-up, 6 month follow-up, 9 month follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Participation in Recovery Behaviors Over Time
Time Frame: baseline, discharge, 3-, 6- and 9-month follow-ups
Recovery behaviors defined as mean number of days doing extracurricular/recovery-goal directed activities using repeated measures over time.
baseline, discharge, 3-, 6- and 9-month follow-ups
Recovery Confidence (Self-efficacy) Over Time
Time Frame: baseline, discharge, 3-, 6-, and 9-month follow-ups
Change/improvements in mean recovery confidence score over time (measured by question "How confident are you in your ability to be completely abstinent (clean) from alcohol and drugs in the next 30 days?" (units on scale included 0=not at all, 1=slightly, 2=moderately, 3=considerably, 4-extremely).
baseline, discharge, 3-, 6-, and 9-month follow-ups
Social Support Utilization
Time Frame: Baseline, discahrge, 3 month follow-up, 6 month follow-up, 9 month follow-up
Self-help utilization was measured by the question: "In the past 30 days, how many days did you attend self-help meetings like AA or NA to support your recovery?"
Baseline, discahrge, 3 month follow-up, 6 month follow-up, 9 month follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Azusa Pacific University

Collaborators

National Institute on Drug Abuse (NIDA)
University of California, Los Angeles

Investigators

  • Principal Investigator: Rachel Gonzales-Castaneda, MPH, PhD, Azusa Pacific University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2012

Primary Completion (Actual)

December 1, 2014

Study Completion (Actual)

June 1, 2015

Study Registration Dates

First Submitted

June 29, 2012

First Submitted That Met QC Criteria

July 2, 2012

First Posted (Estimate)

July 3, 2012

Study Record Updates

Last Update Posted (Estimate)

August 21, 2015

Last Update Submitted That Met QC Criteria

July 28, 2015

Last Verified

July 1, 2015

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 5K01DA027754-03 (U.S. NIH Grant/Contract)
  • 1K01DA027754-01A1 (U.S. NIH Grant/Contract)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Addiction

Clinical Trials on Mobile Continuing Care

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe